Timing of factor VIIa in liver transplantation impacts cost and clinical outcomes.

@article{Scheffert2013TimingOF,
  title={Timing of factor VIIa in liver transplantation impacts cost and clinical outcomes.},
  author={Jenna L Scheffert and David J Taber and Nicole Ann Pilch and John W. McGillicuddy and Prabhakar K Baliga and Kenneth D Chavin},
  journal={Pharmacotherapy},
  year={2013},
  volume={33 5},
  pages={483-8}
}
STUDY OBJECTIVE To investigate the clinical and economic outcomes associated with the use of recombinant factor VIIa (rFVIIa) in perioperative liver transplantation (LT). DESIGN Retrospective review. SETTING Academic medical center. PATIENTS A total of 63 adults who underwent LT between January 2000 and September 2008 and received rFVIIa prior to or… CONTINUE READING